Effect of IL-1β and TNF-α polymorphisms on the prognosis and survival of gastric cancer patients

Clinical and Experimental Medicine

Volumn 11, Issue 4, 2011, Pages 211-217

  Tahara, Tomomitsu ^a   Shibata, Tomoyuki ^a   Nakamura, Masakatsu ^a   Yamashita, Hiromi ^a   Yoshioka, Daisuke ^a   Okubo, Masaaki ^a   Yonemura, Joh ^a   Maeda, Yoshiteru ^a   Maruyama, Naoko ^a   Kamano, Toshiaki ^a   Kamiya, Yoshio ^a   Fujita, Hiroshi ^a   Nakagawa, Yoshihito ^a   Nagasaka, Mitsuo ^a   Iwata, Masami ^a   Hirata, Ichiro ^a   Arisawa, Tomiyasu ^b  

^a FUJITA HEALTH UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b KANAZAWA MEDICAL UNIVERSITY   (Japan)

Author keywords

Gastric cancer; Interleukin 1 ; Polymorphism; Tumor necrosis factor

Indexed keywords

INTERLEUKIN 1BETA; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CANCER INVASION; CANCER PATIENT; CANCER RISK; CANCER SURVIVAL; DNA POLYMORPHISM; FEMALE; GENETIC ASSOCIATION; GENOTYPE; HETEROZYGOTE; HUMAN; HUMAN TISSUE; LYMPH NODE METASTASIS; LYMPHATIC SYSTEM; MAJOR CLINICAL STUDY; MALE; OVERALL SURVIVAL; PERITONEUM METASTASIS; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; PROGNOSIS; RESTRICTION FRAGMENT LENGTH POLYMORPHISM; STOMACH CANCER; VEIN;

AGED; FEMALE; GENE FREQUENCY; GENETIC ASSOCIATION STUDIES; GENOTYPE; HUMANS; INTERLEUKIN-1BETA; MALE; MIDDLE AGED; POLYMORPHISM, RESTRICTION FRAGMENT LENGTH; POLYMORPHISM, SINGLE NUCLEOTIDE; PROGNOSIS; STOMACH NEOPLASMS; SURVIVAL ANALYSIS; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84855690271     PISSN: 15918890     EISSN: 15919528     Source Type: Journal    
DOI: 10.1007/s10238-010-0129-y     Document Type: Article

References (24)

1. Parkin DM, Whelan SL, Ferlay J, Raymond L, Young J (1997) Cancer incidence in five continents, volume VII. IARC Press, Lyon
2. Parkin DM, Pisani P, Ferlay J (1999) Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80:827-841 (Pubitemid 29108856)
3. Coussens LM, Werb Z (2002) Inflammation and cancer. Nature 420:860-867 (Pubitemid 36019639)
4. Hussain SP, Hofseth LJ, Harris CC (2003) Radical causes of cancer. Nat Rev Cancer 3:276-285 (Pubitemid 37328863)
5. Wang M, Furuta T, Takashima M, Futami H, Shirai N, Hanai H, Kaneko E (1999) Relation between interleukin-1beta messenger RNA in gastric fundic mucosa and gastric juice pH in patients infected with Helicobacter pylori. J Gastroenterol 34((Suppl 11)):10-17 (Pubitemid 30072480)
6. Yamaoka Y, Kita M, Kodama T, Sawai N, Kashima K, Imanishi J (1997) Induction of various cytokines and development of severe mucosal inflammation by cagA gene positive Helicobacter pylori strains. Gut 41:442-451
7. Hamilton SR, Aaltonen LA (2000) Pathology and genetics. IARC Press, Tumours of the digestive system. WHO Classification of Tumours. Lyon
8. Hwang IR, Kodama T, Kikuchi S, Sakai K, Peterson LE, Graham DY, Yamaoka Y (2002) Effect of interleukin 1 polymorphisms on gastric mucosal interleukin 1beta production in Helicobacter pylori infection. Gastroenterology 123:1793-1803 (Pubitemid 35408303)
9. Wallace JL, Cucala M, Mugridge K, Parente L (1991) Secretagogue-specific effects of interleukin-1 on gastric acid secretion. Am J Physiol 261:G559-G564
10. Zeng ZR, Hu PJ, Hu S, Pang RP, Chen MH, Ng M, Sung JJ (2003) Association of interleukin 1B gene polymorphism and gastric cancers in high and low prevalence regions in China. Gut 52:1684-1689 (Pubitemid 37510386)
11. Higuchi T, Seki N, Kamizono S, Yamada A, Kimura A, Kato H, Itoh K (1998) Polymorphism of the 50-flanking region of the human tumor necrosis factor (TNF) -alpha gene in Japanese. Tissue Antigens 51:605-612 (Pubitemid 28306464)
12. Soga Y, Nishimura F, Ohyama H, Maeda H, Takashiba S, Murayama Y (2003) Tumor necrosis factor-alpha gene (TNFalpha) -1031/-863-857 single-nucleotide polymorphisms (SNPs) are associated with severe adult periodontitis in Japanese. J Clin Periodontol 30:524-531 (Pubitemid 38011182)
13. Sugimoto M, Furuta T, Shirai N, Nakamura A, Xiao F, Kajimura M, Sugimura H, Hishida A (2007) Different effects of polymorphisms of tumor necrosis factor-alpha and interleukin-1 beta on development of peptic ulcer and gastric cancer. J Gastroenterol Hepatol 22:51-59 (Pubitemid 44953416)
14. El-Omar EM, Carrington M, Chow WH, McColl KEL, Bream JH, Young HA, Herrera J, Lissowska J, Yuan CC, Rothaman N, Lanyan G, Martin M, Fraumeni JF Jr, Rabkin CS (2000) Interleukin-1 polymorphisms associated with increased risk of gastric cancer. Nature 404:398-402 (correction published in Nature 2001;412:99) (Pubitemid 30164342)
15. Figueiredo C, Machado JC, Pharoah P, Seruca R, Sousa S, Carvalho R, Capelinha AF, Quint W, Caldas C, van Doorn LJ, Carneiro F, Sobrinho-Simões M (2002) Helicobacter pylori and interleukin 1 genotyping: An opportunity to identify high-risk individuals for gastric carcinoma. J Natl Cancer Inst 94:1680-1687 (Pubitemid 35446836)
16. Machado JC, Pharoah P, Sousa S, Carvalho R, Oliveira C, Figueiredo C, Amorim A, Seruca R, Caldas C, Carneiro F, Sobrinho-Simões M (2001) Interleukin 1B and interleukin 1RN polymorphisms are associated with increased risk of gastric carcinoma. Gastroenterology 121:823-829 (Pubitemid 32959393)
17. Lauren P (1965) The two histological main types of gastric carcinoma: Diffuse and so-called intestinal-type carcinoma. An attempt at a histo-clinical classification. Acta Pathol Microbiol Scand 64:31-49
18. Gotoda T, Yanagisawa A, Sasako M, Ono H, Nakanishi Y (2000) Shimoda T and Kato Y: Incidence of lymph node metastasis from early gastric cancer:estimation with a large number of cases at two large centers. Gastric Cancer 3:219-225 (Pubitemid 32290729)
19. Deans DA, Wigmore SJ, Gilmour H, Paterson-Brown S, Ross JA, Fearon KC (2006) Elevated tumour interleukin-1beta is associated with systemic inflammation: A marker of reduced survival in gastro-oesophageal cancer. Br J Cancer 95:1568-1575 (Pubitemid 44863361)
20. Ballaz S, Mulshine JL (2003) The potential contributions of chronic inflammation to lung carcinogenesis. Clin Lung Cancer 5:46-62 (Pubitemid 36974741)
21. Graziano F, Ruzzo A, Santini D, Humar B, Tonini G, Catalano V, Berardi R, Pizzagalli F, Arduini F, Bearzi I, Scartozzi M, Cascinu S, Testa E, Ficarelli R, Magnani M (2005) Prognostic role of interleukin-1beta gene and interleukin-1 receptor antagonist gene polymorphisms in patients with advanced gastric cancer. J Clin Oncol 23:2339-2345 (Pubitemid 46218727)
22. Barth RJ Jr, Camp BJ, Martuscello TA, Dain BJ, Memoli VA (1996) The cytokine microenvironment of human colon carcinoma. Lymphocyte expression of tumor necrosis factor-a and interleukin-4 predicts improved survival. Cancer 78: 1168-1178 (Pubitemid 26303881)
23. Yurkovetsky ZR, Kirkwood JM, Edington HD, Marrangoni AM, Velikokhatnaya L, Winans MT, Gorelik E, Lokshin AE (2007) Multiplex analysis of serum cytokines in melanoma patients treated with interferon-alpha2b. Clin Cancer Res 13:2422-2428 (Pubitemid 46698593)
24. van Horssen R, Ten Hagen TL, Eggermont AM (2006) TNFalpha in cancer treatment: Molecular insights, antitumor effects, and clinical utility. Oncologist 11:397-408